Habil Khorakiwala

Type: Person

Name: Habil Khorakiwala

Title: Chairman

company: Wockhardt

Nationality: India

Fact Sheet: Biography for Habil Khorakiwala

First reported Jun 14 2013 - Updated Jun 14 2013 - 1 reports

Habil Khorakiwala

Wockhardt gets kicked in the gut again

India's ban on painkiller shaves revenue after U.S. import alert affects $100 million in salesShareToolsThere is more financially painful news for India's Wockhardt. India has banned the sale of painkiller dextropropoxyphene, and Wockhardt's branded version, ... [Published FiercePharma - Jun 14 2013]

Entities: Wockhardt Ltd, anodyne, India, Habil Khorakiwala

First reported May 29 2013 - Updated May 30 2013 - 1 reports

Wockhardt posts consolidated revenue of Rs 5610 crores in FY 2012-13

PAT reported at Rs 1594 croresWockhardt has reported its consolidated revenue of Rs 5610 crores, and a Profit After Tax (PAT) of Rs 1594 crores in the Financial Year 2012‐13. The PAT margin is at 28.4 per cent. Consolidated revenues showed a growth of ... [Published Express Pharma - May 29 2013]

Entities: Wockhardt Ltd, Fiscal Year, Habil Khorakiwala, Operating Profit, Profit Margin

First reported May 28 2013 - Updated May 28 2013 - 1 reports

Wockhardt expects near flat growth for FY14

Pharma major Wockhardt on Tuesday said it is expecting an almost flat growth in the current fiscal year.Talking of this fiscal year’s projection, Murtaza Khorakiwala, managing director, Wockhardt, said: “We expect not to grow too much in 2013-14. Marginal ... [Published Financial Chronicle - May 28 2013]

Entities: Wockhardt Ltd, Habil Khorakiwala, Fiscal Year, Price Control

First reported May 27 2013 - Updated May 28 2013 - 3 reports

Sales across globe help Wockhardt post profit

New Delhi, May 27: Drug firm Wockhardt today reported a consolidated net profit of Rs 334.76 crore for the fourth quarter ended March against a loss of Rs 191.64 crore in the year-ago period, helped by robust international sales. Consolidated net sales ... [Published Calcutta Telegraph - May 28 2013]

Entities: Wockhardt Ltd, Patent, Habil Khorakiwala, Net Profit, Sistema Shyam TeleServices Limited

First reported May 27 2013 - Updated May 27 2013 - 1 reports

DCGI working on policy to respond to safety alerts

NEW DELHI: India's drug regulator is working on a clear policy on how it should respond to safety alerts by foreign regulators on medicines manufactured by Indian companies after two of the country's biggest drug manufacturers landed in trouble with the ... [Published Economic Times - May 27 2013]

Entities: Drugs, Ranbaxy Laboratories Ltd, Cosmetics, FDA Food & Drug Administration

First reported May 27 2013 - Updated May 27 2013 - 1 reports

FDA Food & Drug Administration

After Ranbaxy FDA pulls its guns at Wockhardt

BiospectrumSingapore: The US FDA has sent Indian drugmaker, Wockhardt, an import alert notifying that the import of all drugs manufactured at its Aurangabad production unit in India have been banned.In April 2012, officials from the US FDA had conducted ... [Published Bio Spectrum Asia - May 27 2013]

Entities: Wockhardt Ltd, FDA Food & Drug Administration, Ranbaxy Laboratories Ltd

First reported May 25 2013 - Updated May 25 2013 - 1 reports

Ranbaxy Laboratories Ltd

USFDA: Will Ranbaxy, Wockhardt be affected in long-term?

Japanese companies do not mind erring on the side of caution. They are known to think longer and harder than their counterparts in other countries about big decisions, especially when it comes to entering a new market or acquiring a foreign company. But ... [Published Economic Times - May 25 2013]

Entities: Ranbaxy Laboratories Ltd, Wockhardt Ltd, Sterling Biotech Ltd, Habil Khorakiwala

First reported May 25 2013 - Updated May 25 2013 - 2 reports

Wockhardt staring at a crisis?

It's free!Get Rediff News delivered into your Inbox dailyThe US Food and Drug Administration has issued an import alert on Wockhardt’s manufacturing plant at Waluj, Aurangabad.In a conference called, Habil Khorakiwala, Chairman, Wockhardt, clarified the ... [Published rediff.com - May 25 2013]

Entities: Wockhardt Ltd, Habil Khorakiwala, FDA Food & Drug Administration

First reported May 24 2013 - Updated May 24 2013 - 3 reports

‘Wockhardt to take Rs 550-cr hit from FDA rap’

The import alert issued by the (FDA) on one of Wockhardt?s Indian manufacturing facilities could not have come at a more inopportune time for the Mumbai-based drug-maker, as well as for the domestic pharmaceutical industry.An "import alert" results in ... [Published Hindu Business Line - May 24 2013]

Entities: Wockhardt Ltd, FDA Food & Drug Administration, Manufacturing, Ranbaxy Laboratories Ltd

First reported May 24 2013 - Updated May 24 2013 - 1 reports

Wockhardt may suffer $100M sales loss due to FDA’s ‘import alert’

Drug manufacturer Wockhardt has announced that the US Food & Drug Administration's (FDA's) import alert on one of its plants could cause a sales loss of $100 million (Rs 550 crore).The US food watchdog has recently expressed concern on Wockhardt products ... [Published TopNews Spain - May 24 2013]

Entities: Wockhardt Ltd, FDA Food & Drug Administration, Habil Khorakiwala, Aurangabad (India)

First reported May 23 2013 - Updated May 24 2013 - 24 reports

Wockhardt shares fall for 2nd day; slump 19% in early trade

Extending losses for the second day in a row, shares of Wockhardt on Friday plummeted by over 19%, after the company said import alert issued by US health regulator on its manufacturing facility near Aurangabad could impact the company's business by $100 ... [Published Hindustan Times - May 24 2013]

Entities: Wockhardt Ltd, Aurangabad (Maharashtra, India), Stocks

First reported May 24 2013 - Updated May 24 2013 - 1 reports

After Ranbaxy...Wockhardt under scanner

Habil Khorakiwala, chairman, Wockhardt, reported that the company was expecting a loss of up to $100 mn in annualised revenue, owing to the import alert. According to reports, after the Ranbaxy, Wockhardt is under the scanner, as US regulator raising ... [Published India Infoline - May 24 2013]

Entities: Wockhardt Ltd, Ranbaxy Laboratories Ltd, Habil Khorakiwala

Quotes

"the strong growth that we have achieved in this financial year is the result of a robust global strategy, continued focus on generic research and the commitment and confidence of team wockhardt. driving profitable growth is integral to our business strategy" said Habil Khorakiwala, founder chairman and group chief executive officer, Wockhardt

BRIEF: Wockhardt posts Rs.335 crore profit in Q4 [Published Individual.com - May 27 2013]

"it's going to be challenging to regain market share following the us fda import ban on aurangabad plant. the company may lose out to new competition. the pending drug filings from the same facility may also get delayed" said Habil Khorakiwala, chairman of Wockhardt

Wockhardt shares tumble 20% after USFDA import ban [Published Economic Times - May 24 2013]

More Content

sort by: Date \| Relevance
Wockhardt gets kicked in the gut again [Published FiercePharma - Jun 14 2013]
Wockhardt to Lose $17 Million in Sales as India... [Published Bloomberg - Jun 13 2013]
Frost & Sullivan Invites Entries for the Covete... [Published IT News Online - Jun 04 2013]
Frost & Sullivan Invites Entries For ... [Published EFYTimes.com - Jun 04 2013]
Wockhardt posts consolidated revenue of Rs 5610... [Published Express Pharma - May 29 2013]
Wockhardt expects near flat growth for FY14 [Published Financial Chronicle - May 28 2013]
Sales across globe help Wockhardt post profit [Published Calcutta Telegraph - May 28 2013]
Wockhardt net up on overseas sales [Published Financial Chronicle - May 27 2013]
BRIEF: Wockhardt posts Rs.335 crore profit in Q4 [Published Individual.com - May 27 2013]
Wockhardt Q4 net profit at Rs 334.76 crore [Published The Hindu - May 27 2013]
After Ranbaxy FDA pulls its guns at Wockhardt [Published Bio Spectrum Asia - May 27 2013]
DCGI working on policy to respond to safety alerts [Published Economic Times - May 27 2013]
USFDA: Will Ranbaxy, Wockhardt be affected in l... [Published Economic Times - May 25 2013]
Wockhardt staring at a crisis? [Published rediff.com - May 25 2013]
Sebi silver jubilee celebrations: Damodaran, Bh... [Published msn.co.in - May 25 2013]
Wockhardt says speeding up process to be up to ... [Published DNA India - May 25 2013]
Wockhardt shares tumble 20% after USFDA import ban [Published Economic Times - May 24 2013]
‘Wockhardt to take Rs 550-cr hit from FDA rap’ [Published Hindu Business Line - May 24 2013]
Wockhardt drug approvals seen delayed after US ... [Published Livemint.com - May 24 2013]
Wockhardt may suffer $100M sales loss due to FD... [Published TopNews Spain - May 24 2013]
Wockhardt Drug Filings Seen Delayed After U.S. ... [Published Bloomberg - May 24 2013]
Wockhardt too a part of FDA toxic capsule [Published EHealth Magazine - May 24 2013]
Wockhardt shares fall for 2nd day; slump 19% in... [Published Hindustan Times - May 24 2013]
Wockhardt shares fall for 2nd day; slump 19% in... [Published Deccan Herald - May 24 2013]
Wockhardt shares recover after diving 19% [Published Hindu Business Line - May 24 2013]
Wockhardt shares fall for 2nd day; slump 19% [Published zeenews.com - May 24 2013]
Wockhardt slumps after FDA import alert [Published India Infoline - May 24 2013]
After Ranbaxy saga, investors spooked by US imp... [Published Firstpost.com - May 24 2013]
Wockhardt shares recover after plunging 19% [Published NDTV Profit - May 24 2013]
FDA import alert a Rs 550 crore hit for Wockhardt [Published DNA India - May 24 2013]